The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > CV Therapeutics, Inc.

CV Therapeutics, Inc.
Nasdaq: CVTX
Change
symbol:
     
 NEWS FROM THE WIRES
CV Therapeutics loss widens on higher spending
Jul 18 2001 04:14 AM PDT

More WIRE STORIES about this company

 PROFILE
CV Therapeutics is a development-stage company specializing in small-molecule drugs to treat chronic cardiovascular diseases. Through its expertise in molecular cardiology, the firm has developed three lead product canditates. Ranolazine, originally licensed from Roche subsidiary Syntex, would treat angina by altering metabolism and has reached Phase III trials. CVT-510 is a potential treatment for arrhythmia that slows electrical impulses to the heart, while CVT-3146 is a potential cardiac imaging agent. The company is developing a treatment for congestive heart failure with Biogen and has inked a deal to have Quintiles Transnational subsidiary Innovex market Ranolazine in the US if the FDA approves it.

 COMPETITION
GlaxoSmithKline plc (GSK)
Merck & Co., Inc. (MRK)
Pfizer Inc (PFE)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 3.30
1-Yr. Sales Growth: 3,200.0%
Employees: 134
Revenue per employee: $24,626.87

 KEY PEOPLE
• Louis G. Lange
    CEO
• Daniel K. Spiegelman
    CFO

 CONTACT INFO
3172 Porter Dr.
Palo Alto, CA 94304
US
Phone: 650-812-0585
Fax: 650-858-0390
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001